ACTIVE

FUJIREBIO EUROPE

Export PDF

Financial year 2026 · Closed on 31/03/2026

Net result-2,7 M €-152,5 %over 1 year

Revenue51,4 M €+28,1 %over 1 year

Equity45,7 M €-5,6 %over 1 year

Workforce141,0 ETP+0,4 %over 1 year

Identity

Source · BCE/KBO

FUJIREBIO EUROPE is a Public limited company incorporated in 1985. Its main activity is: Manufacture of other chemical products n.e.c.. Its registered office is in Gent. It employs on average 141,0 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0427.550.660
Incorporation: 18/07/1985
Legal form: Public limited company
Registered office: Technologiepark-Zwijnaarde 6
9052 Gent · FlandreSee on map
Contributed capital: 31 398 322,00 €
Latest accounts: 31/03/2026
Average workforce: 141,0 ETP

Activities (NACE)

20590Manufacture of other chemical products n.e.c.· main 20590Manufacture of other chemical products n.e.c.24660Manufacture of basic metals 72101Research and experimental development on natural sciences and engineering 72110Research and experimental development on biotechnology

Joint committees (4)

Signals

Solid equityPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 28 filings

Trend over 17 financial years

	2026		2025		2024		2023		2022
Income statement
Revenue	51,4 M €	+28.1%	40,1 M €	+18.1%	34 M €	+2.1%	33,3 M €	-27.6%	45,9 M €
EBITDA	15 M €	+91.3%	7,8 M €	+195%	2,7 M €	+1657%	151,2 k €	-98.1%	7,9 M €
Operating result	12,6 M €	+71.4%	7,3 M €	+1957%	-395,6 k €	+65.2%	-1,1 M €	-118%	6,4 M €
Net result	-2,7 M €	-153%	5,2 M €	+1015%	-567,1 k €	+68.6%	-1,8 M €	-131%	5,9 M €
Balance sheet
Equity	45,7 M €	-5.6%	48,4 M €	+12.0%	43,3 M €	+27.9%	33,8 M €	-5.1%	35,6 M €
Total assets	81,8 M €	-8.6%	89,5 M €	+2.0%	87,8 M €	+0.9%	87 M €	+83.9%	47,3 M €
Cash	3,4 M €	+4.5%	3,3 M €	-6.7%	3,5 M €	+1.6%	3,5 M €	-8.8%	3,8 M €
Debts	36 M €	-11.6%	40,7 M €	-8.3%	44,4 M €	-15.8%	52,8 M €	+369%	11,3 M €
Other
Workforce	141,0 ETP	+0.4%	140,4 ETP	+4.3%	134,6 ETP	+4.7%	128,6 ETP	-2.7%	132,2 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 25 M€ and 50 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/03/2026

0 active · 30 ended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
TADASHI NINOMIYA	Director01/04/2026 → 19/06/2026
AOKI KOJI	Director17/06/2022 → 20/06/2025

Other companies at this address

Technologiepark-Zwijnaarde 6 9052 Gent

Company	CBE no.
ADx NeuroSciences● Active	0839.400.980
FujiADx● Active	1004.979.782

Full financial information

Source · NBB

	2026	2025	2024	2023	2022	2021
Type of account	Full model	Full model	Full model	Full model	Consolidated accounts	Full model
Start of the financial year	01/04/2025	01/04/2024	01/04/2023	01/04/2022	01/04/2021	01/04/2020
Closing of the financial year	31/03/2026	31/03/2025	31/03/2024	31/03/2023	31/03/2022	31/03/2021
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	24/06/2026	07/07/2025	04/07/2024	19/06/2023	19/07/2022	22/06/2021
General meeting	19/06/2026	20/06/2025	21/06/2024	16/06/2023	21/06/2022	18/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	JPY	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 28 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/03/2026	19/06/2026	24/06/2026	Dutch	PDF
Consolidated accounts	31/03/2026	16/06/2026	24/06/2026	English	PDF
Full model	31/03/2025	20/06/2025	07/07/2025	Dutch	PDF
Consolidated accounts	31/03/2025	17/06/2025	23/07/2025	English	PDF
Full model	31/03/2024	21/06/2024	04/07/2024	Dutch	PDF
Consolidated accounts	31/03/2024	18/06/2024	17/07/2024	English	PDF
Full model	31/03/2023	16/06/2023	19/06/2023	Dutch	PDF
Consolidated accounts	31/03/2023	20/06/2023	04/08/2023	English	PDF
Full model	31/03/2022	17/06/2022	24/06/2022	Dutch	PDF
Consolidated accounts	31/03/2022	21/06/2022	19/07/2022	Dutch	PDF
Full model	31/03/2021	18/06/2021	22/06/2021	Dutch	PDF
Full model	31/03/2020	19/06/2020	06/07/2020	Dutch	PDF
Full model	31/03/2019	21/06/2019	08/07/2019	Dutch	PDF
Full model	31/03/2018	15/06/2018	05/07/2018	Dutch	PDF
Full model	31/03/2017	16/06/2017	22/06/2017	Dutch	PDF
Full model	31/03/2016	17/06/2016	01/07/2016	Dutch	PDF
Full model	31/03/2015	19/06/2015	14/07/2015	Dutch	PDF
Full model	31/03/2014	25/06/2014	17/07/2014	Dutch	PDF
Full model	31/03/2013	19/06/2013	15/07/2013	Dutch	PDF
Full model	31/03/2012	19/06/2012	30/07/2012	Dutch	PDF
Full model	31/03/2011	17/06/2011	01/07/2011	Dutch	PDF
Full modelCorrection	31/12/2009	30/08/2010	04/03/2011	Dutch	PDF
Full model	31/12/2009	30/06/2010	11/08/2010	Dutch	PDF
Full model	31/12/2008	27/03/2009	14/07/2009	Dutch	PDF
Full model	31/12/2007	28/03/2008	28/04/2008	Dutch	PDF
Consolidated accounts	31/12/2007	28/03/2008	20/05/2008	Dutch	PDF
Full model	31/12/2006	30/03/2007	20/04/2007	Dutch	PDF
Consolidated accounts	31/12/2006	30/03/2007	25/04/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 25 M€ and 50 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/03/2026

0 active · 30 ended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
TADASHI NINOMIYA	Director01/04/2026 → 19/06/2026
AOKI KOJI	Director17/06/2022 → 20/06/2025

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates28/07/2026
ONTSLAGEN - BENOEMINGEN
PDF
Restructuring08/05/2026
DOEL - KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates04/05/2026
ONTSLAGEN - BENOEMINGEN
PDF
Restructuring19/02/2026
KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates14/10/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates03/10/2024
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares12/01/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
PDF
Mandates04/09/2023
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings17 filings

Mandates

TADASHI NINOMIYA

CDW INVEST

KURT TROCH

AOKI KOJI

MONTE WILTSE

SATOSHI SAITO

KATSUMI AOYAGI

GOKI ISHIKAWA

CHRISTINA HALL

TAKESHI KOYAMA

NAOYOSHI KUBOTA

YOSHIHIRO ASHIHARA

and 10 more mandates

198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026

FUJIREBIO EUROPEINNOGENETICS

Technologiepark-Zwijnaarde 6, 9052 Zwijnaarde

Director

Managing directorDirector

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Technologiepark-Zwijnaarde 6, 9052 ZwijnaardeCurrent	accounts 2023 → 2026	Accounts 2026 · 2026-00199533

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
FUJIREBIO EUROPECurrent	accounts 2014 → 2026	Accounts 2026 · 2026-00199533
INNOGENETICS	accounts 2007 → 2013	Accounts 2013 · 2013-30700073

Events

01/04/2026
autre
01/04/2026
nominationTadashi Ninomiya · Bestuurder
2026
Annual accounts 2026-2,7 M €↓
20/06/2025
reconductionGoki Ishikawa · lid van de Raad van Bestuur
20/06/2025
reconductionKoji Aoki · lid van de Raad van Bestuur
20/06/2025
reconductionKurt Troch · lid van de Raad van Bestuur
2025
Annual accounts 20255,2 M €↑
21/06/2024
reconductionGoki Ishikawa · leden van de Raad van Bestuur
21/06/2024
reconductionKoji Aoki · leden van de Raad van Bestuur
21/06/2024
reconductionKurt Troch · leden van de Raad van Bestuur
21/06/2024
nominationWouter Coppens · commissaris
2024
Annual accounts 2024-567,1 k €↑
16/06/2023
reconductionGoki Ishikawa · leden van de Raad van Bestuur
16/06/2023
reconductionKurt Troch · leden van de Raad van Bestuur
2023
Annual accounts 2023-1,8 M €↓
23/07/2022
autre
17/06/2022
nominationGoki Ishikawa · lid van de Raad van Bestuur
17/06/2022
nominationKoji Aoki · lid van de Raad van Bestuur
17/06/2022
nominationCDW Invest BV · lid van de Raad van Bestuur
17/06/2022
nominationKurt Troch · lid van de Raad van Bestuur
2022
Annual accounts 20225,9 M €↑
2021
Annual accounts 20214,2 M €↑
2020
Annual accounts 2020-1,7 M €↓
2019
Annual accounts 2019-283,5 k €↓
2018
Annual accounts 20186,1 M €↑
2017
Annual accounts 20175,7 M €↓
2016
Annual accounts 201611,4 M €↑
2015
Annual accounts 20154,9 M €↑
2014
Annual accounts 20144 M €↓
2014
Name changeFUJIREBIO EUROPE
2013
Annual accounts 20136,2 M €↓
2012
Annual accounts 20126,5 M €↑
2011
Annual accounts 2011-8 M €↑
2007
Annual accounts 2007-16,9 M €
18/07/1985
IncorporationPublic limited company

FUJIREBIO EUROPE

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events